REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs

Clinical trial NCT05223413 · RECRUITING

Trial details

NCT number: NCT05223413
Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Anthracycline-induced Cardiac Toxicity Lymphoma

Start date: 2022-01-18
Primary completion: 2026-06-01
Enrollment: 608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.